Your RSA-2048 keys break in 2030. Find every one of them before attackers do.
🛡️
CISA KEV · ACTIVELY EXPLOITED
HIGH severity

CVE-2026-33825

HIGH

CVE-2026-33825 is a high-severity (CVSS 7.8) CWE-1220 vulnerability in microsoft defender antimalware platform. It is in CISA's Known Exploited Vulnerabilities catalog (added 2026-04-22) and has been used in ransomware campaigns — treat it as actively exploited and patch now. O3 Security detects and blocks CVE-2026-33825 exploitation at runtime via eBPF exploit-chain detection and L7 egress monitoring, even on unpatched systems.

Insufficient granularity of access control in Microsoft Defender allows an authorized attacker to elevate privileges locally.

Published
Apr 14, 2026
Updated
Jul 24, 2026
Affected
1 product
Patched
See advisory
Exploits
3 known
Exploitation data as of Aug 27, 2026 · OSV.dev, NVD, CISA KEV, FIRST.org (EPSS)

Exploitation Status

Actively exploited in the wild

  • Confirmed by CISA's Known Exploited Vulnerabilities catalog on 2026-04-22 — including use in ransomware campaigns. Federal agencies were required to remediate by 2026-05-06.
  • A successful exploit gives an attacker total control of the affected component, not partial access.

Exploitation and automatability from CISA (KEV catalog and SSVC triage) for CVE-2026-33825.

EPSS Exploitation Probability

via FIRST.org ↗
6.7%probability of exploitation in next 30 days
Lower Risk0.00%
Lower risk than most CVEs93th percentile — riskier than 93% of all scored CVEsHighest risk
2.17%4.18%6.19%8.20%3.3%7.1%6.7%6.7%6.7%May 26Jul 26Aug 26

EPSS (Exploit Prediction Scoring System) is a daily probability model maintained by FIRST.org. It estimates the likelihood a CVE will be exploited in production environments within the next 30 days, derived from real-world threat intelligence signals.

How urgent is this, really

CVE-2026-33825 plotted by exploitation likelihood (EPSS) against impact (CVSS). The shaded corner — EPSS 50%+ and CVSS 7.0+ — is where this CVE doesn't sit, though severity or exploitability alone can still warrant action.

Where this sits among everything scored

Of 0 CVEs with a current EPSS score, this one falls in the < 10% band (highlighted). Real counts from FIRST.org, not a sample — log-scaled since the landscape is heavily right-skewed.

Description

Insufficient granularity of access control in Microsoft Defender allows an authorized attacker to elevate privileges locally.

Affected Products

1 product · 1 configurations
Application
defender antimalware platformmicrosoft
< 4.18.26030.3011
range
Exploits & PoCs
3

Research use only. For defensive security, authorized penetration testing, and academic research only. Never execute exploit code against systems without explicit written authorization.

Detection & mitigation playbook

Vendor / appliance
  1. Detect

    Inventory every microsoft defender antimalware platform deployment and check each version against the affected-products list above. Because the exploit targets the running system rather than your application code, also watch for exploitation at the network and runtime layer — O3 flags the exploit behaviour from runtime telemetry and egress traffic even before a vulnerable build is confirmed.

  2. Fix

    Apply the microsoft defender antimalware platform security patch or hotfix for CVE-2026-33825 on the affected version, following the vendor advisory for your exact build.

  3. Workarounds

    Cut exposure now: restrict the management/admin interface to trusted networks, segment the device, and apply the vendor's recommended configuration mitigations and any WAF/IPS signature. O3's runtime protection blocks the exploit chain at execution, holding the line on unpatched or end-of-life systems until you can patch.

  4. How O3 protects you

    O3 detects and blocks CVE-2026-33825 exploitation at runtime: eBPF exploit-chain detection, plus L7 egress monitoring that catches the post-exploitation callback and severs the attacker's outbound channel.

Tailored to CVE-2026-33825. Runtime protection reduces exposure until a permanent patch is applied and verified — it complements patching, it doesn't replace it.

Frequently Asked Questions

Insufficient granularity of access control in Microsoft Defender allows an authorized attacker to elevate privileges locally.
O3 Security · Runtime Protection

Is CVE-2026-33825 being exploited in your environment?

O3's eBPF runtime sensors and L7 egress monitoring detect and block the CVE-2026-33825 exploit chain at execution — protecting unpatched and end-of-life systems until the vendor patch is applied.

CVE-2026-33825: Defender Antimalware… | O3 Security